Radicava ORS 105 mg/5 mL oral suspension Images
Generic Name: edaravone
This medication has been identified as Radicava ORS 105 mg/5 mL oral suspension. It is supplied by Mitsubishi Tanabe Pharma America, Inc.
Radicava ORS is used in the treatment of Amyotrophic Lateral Sclerosis and belongs to the drug class miscellaneous central nervous system agents. Radicava ORS 105 mg/5 mL oral suspension is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Radicava ORS
- Generic Name
- edaravone
- Strength
- 105 mg/5 mL oral suspension
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mitsubishi Tanabe Pharma America, Inc.
- Manufacturer
- Mitsubishi Tanabe Pharma Corporation
- National Drug Code (NDC)
- 70510-2321
More about Radicava ORS (edaravone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
